Literature DB >> 17878164

Activity-dependent neuroprotective protein constitutes a novel element in the SWI/SNF chromatin remodeling complex.

Shmuel Mandel1, Illana Gozes.   

Abstract

Complete deficiency in activity-dependent neuroprotective protein (ADNP), a heterochromatin 1-binding protein, results in dramatic changes in gene expression, neural tube closure defects, and death at gestation day 9 in mice. To further understand the cellular roles played by ADNP, the HEK293 human embryonic kidney cell line that allows efficient transfection with recombinant DNA was used as a model for the identification of ADNP-interacting proteins. Recombinant green fluorescent protein (GFP)-ADNP was localized to cell nuclei. When nuclear extracts were subjected to immunoprecipitation with specific GFP antibodies followed by polyacrylamide gel electrophoresis, several minor protein bands were observed in addition to GFP-ADNP. In-gel protein digests followed by mass spectrometry identified BRG1, BAF250a, and BAF170, all components of the SWI/SNF (mating type switching/sucrose nonfermenting) chromatin remodeling complex, as proteins that co-immunoprecipitate with ADNP. These results were verified utilizing BRG1 antibodies. ADNP short hairpin RNA down-regulation resulted in microtubule reorganization and changes in cell morphology including reduction in cell process formation and cell number. These morphological changes are closely associated with the SWI/SNF complex multifunctionality. Taken together, the current study uncovers a molecular basis for the essential function of the ADNP gene and protein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17878164     DOI: 10.1074/jbc.M704756200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

Review 1.  Microtubule-Tau Interaction as a Therapeutic Target for Alzheimer's Disease.

Authors:  Yanina Ivashko Pachima; Liu-yao Zhou; Peng Lei; Illana Gozes
Journal:  J Mol Neurosci       Date:  2016-02       Impact factor: 3.444

2.  ADNP/ADNP2 expression in oligodendrocytes: implication for myelin-related neurodevelopment.

Authors:  Anna Malishkevich; Janina Leyk; Olaf Goldbaum; Christiane Richter-Landsberg; Illana Gozes
Journal:  J Mol Neurosci       Date:  2015-10       Impact factor: 3.444

Review 3.  Neuroprotective protein and carboxypeptidase E.

Authors:  Hisatsugu Koshimizu; Vladimir Senatorov; Y Peng Loh; Illana Gozes
Journal:  J Mol Neurosci       Date:  2009-01-23       Impact factor: 3.444

4.  Chromatin-modifying agents for epigenetic reprogramming and endogenous neural stem cell-mediated repair in stroke.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Transl Stroke Res       Date:  2011-03-01       Impact factor: 6.829

5.  A unique missense allele of BAF155, a core BAF chromatin remodeling complex protein, causes neural tube closure defects in mice.

Authors:  Laura Harmacek; Dawn E Watkins-Chow; Jianfu Chen; Kenneth L Jones; William J Pavan; J Michael Salbaum; Lee Niswander
Journal:  Dev Neurobiol       Date:  2014-01-09       Impact factor: 3.964

6.  The Compassionate Side of Neuroscience: Tony Sermone's Undiagnosed Genetic Journey--ADNP Mutation.

Authors:  Illana Gozes; Celine Helsmoortel; Geert Vandeweyer; Nathalie Van der Aa; Frank Kooy; Sandra Bedrosian-Sermone
Journal:  J Mol Neurosci       Date:  2015-08       Impact factor: 3.444

7.  Mutations in ADNP affect expression and subcellular localization of the protein.

Authors:  Elisa Cappuyns; Jolien Huyghebaert; Geert Vandeweyer; R Frank Kooy
Journal:  Cell Cycle       Date:  2018-07-17       Impact factor: 4.534

Review 8.  ATP-dependent chromatin remodeling in neural development.

Authors:  Andrew S Yoo; Gerald R Crabtree
Journal:  Curr Opin Neurobiol       Date:  2009-05-11       Impact factor: 6.627

9.  ADNP differential nucleus/cytoplasm localization in neurons suggests multiple roles in neuronal differentiation and maintenance.

Authors:  Shmuel Mandel; Irit Spivak-Pohis; Illana Gozes
Journal:  J Mol Neurosci       Date:  2008-02-20       Impact factor: 3.444

10.  NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-42).

Authors:  Illana Gozes; Inna Divinski; Inbar Piltzer
Journal:  BMC Neurosci       Date:  2008-12-10       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.